University of Birmingham Enterprise welcomes progress in new treatment for Idiopathic Intracranial Hypertension
University of Birmingham Enterprise welcomes the floatation of Invex Therapeutics, which is developing an innovative new treatment approach for Idiopathic Intracranial Hypertension.